The QuantideX qPCR BCR-ABL Kit delivers reliable results quickly, with direct reporting on the International Scale and a deep clinical sensitivity of 0.002% IS (MR4.7). Scalable, high-throughput testing is enabled by QuantideX multiplex assay design and included analysis software. Confidently deliver results with the first FDA-cleared chronic myeloid leukemia monitoring assay for BCR-ABL Major breakpoints (e13a2, e14a2).
